POWERING POSITIVE GLOBAL CHANGE: REVOLUTIONIZING SURGICAL PRACTICE
Smartweave is a game-changing medical device design platform that leverages AI and visual technology to produce the first personalized, bio-compatible implants for soft tissue repair.
We re-imagine the way implants could and should work by positioning ourselves at the confluence of advanced technologies like generative AI, 3D printing and synthetic biology.
Innovation is the fuel of our brand. We were among just three startups chosen globally from a pool of 1000+ ventures to be backed by Dassault Systemes, the world leader in visualization technology.
WE ARE FANATICAL ABOUT DEVELOPING PERSONALIZED BIOMEDICAL IMPLANTS FOR INDIVIDUALS —
NOT THE MASSES.
We are world-class surgeon scientists, entrepreneurial leaders, and bioengineering and AI experts who have developed our core technology, built prototype devices, and scaled venture-backed healthcare companies to industry leadership.
If we were to change the trajectory of how surgical implants deliver value for patients in sub-specialties ranging from urologic, cardiac, orthopedic and even neural implants, we could change the outcomes for millions of patients worldwide.
We are committed to achieving the 3rd SDG: GOOD HEALTH AND WELL-BEING by leveraging our expertise and groundbreaking technologies to advance the field of surgery and positively impact the lives of patients worldwide.
We are disruptive.
We are agile.
We are experts at the top of our fields.
But mostly, we are compassionate and curious humans who continually demand more.
INCREMENTAL IMPROVEMENTS DON'T MOVE FAST ENOUGH
Although surgical implants represent a 50-billion-dollar+ market, innovation has been slowed by incrementalism. The mass-produced implant of the past is failing. Patient needs are not met due to impersonal treatments and even worse, complications leading to bleeding, tissue damage, infection or death.
Recovery times are long, painful and costly.
Our medical practitioners have lived through the debacles, disappointments and high failure rates that have plagued previous generations of implants made by major medical device companies. Biocompatibility and material resilience are critical for success for patients undergoing cardiovascular, neurological, orthopedic or urological surgeries. Optimization must exceed improvisation to enable better patient outcomes, especially at critical care points.
Biocompatibility and material resilience are critical for success for patients undergoing cardiovascular, neurological, orthopedic or urological surgeries.